178 related articles for article (PubMed ID: 33059298)
1. Trends in hospitalizations and epidemiological characteristics of adults Moyamoya disorder in the United States.
Patel SD; Desai N; Rane S; Patel N; Desai R; Mehta T; Ollenschleger MD; Nanda A; Starke RM; Khandelwal P
J Neurol Sci; 2020 Dec; 419():117165. PubMed ID: 33059298
[TBL] [Abstract][Full Text] [Related]
2. Extracranial-Intracranial Bypass for Moyamoya Disease: The Influence of Racial and Socioeconomic Disparities on Outcomes - A National Inpatient Sample Analysis.
Rios-Zermeno J; Ghaith AK; El Hajj VG; Soltan F; Greco E; Michaelides L; Lin MP; Meschia JF; Akinduro OO; Bydon M; Bendok BR; Tawk RG
World Neurosurg; 2024 Feb; 182():e624-e634. PubMed ID: 38061545
[TBL] [Abstract][Full Text] [Related]
3. Socioeconomic and demographic disparities of moyamoya disease in the United States.
Ghaffari-Rafi A; Ghaffari-Rafi S; Leon-Rojas J
Clin Neurol Neurosurg; 2020 May; 192():105719. PubMed ID: 32045710
[TBL] [Abstract][Full Text] [Related]
4. Moyamoya Disease and Syndrome: A National Inpatient Study of Ischemic Stroke Predictors.
Unda SR; Antoniazzi AM; Miller R; Klyde D; Javed K; Fluss R; Holland R; De la Garza Ramos R; Haranhalli N; Altschul DJ
J Stroke Cerebrovasc Dis; 2021 Sep; 30(9):105965. PubMed ID: 34247053
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of and Risk Factors for Cerebral Microbleeds in Moyamoya Disease and Syndrome in the American Population.
Khan NI; Saherwala AA; Chen M; Salehian S; Salahuddin H; Welch BG; Pinho MC; Shang T
Cerebrovasc Dis Extra; 2019; 9(3):139-147. PubMed ID: 31830749
[TBL] [Abstract][Full Text] [Related]
6. Bypass surgery versus medical treatment for symptomatic moyamoya disease in adults.
Jang DK; Lee KS; Rha HK; Huh PW; Yang JH; Park IS; Ahn JG; Sung JH; Han YM
J Neurosurg; 2017 Sep; 127(3):492-502. PubMed ID: 27834597
[TBL] [Abstract][Full Text] [Related]
7. Comparison between moyamoya disease and moyamoya syndrome in Israel.
Schwartzmann Y; Spektor S; Moscovici S; Jubran H; Metanis I; Jouaba T; Cohen JE; Gomori JM; Leker RR
J Stroke Cerebrovasc Dis; 2024 Apr; 33(4):107635. PubMed ID: 38342272
[TBL] [Abstract][Full Text] [Related]
8. Gender and Racial Differences in Hospitalizations for Primary Biliary Cholangitis in the USA.
Adejumo AC; Akhtar DH; Dennis BB; Cholankeril G; Alayo Q; Ogundipe OA; Kim D; Ahmed A
Dig Dis Sci; 2021 May; 66(5):1461-1476. PubMed ID: 32535779
[TBL] [Abstract][Full Text] [Related]
9. National Trends in Hospitalizations for Stroke Associated With Infective Endocarditis and Opioid Use Between 1993 and 2015.
Salehi Omran S; Chatterjee A; Chen ML; Lerario MP; Merkler AE; Kamel H
Stroke; 2019 Mar; 50(3):577-582. PubMed ID: 30699043
[TBL] [Abstract][Full Text] [Related]
10. Socioeconomic factors associated with pediatric moyamoya disease hospitalizations: a nationwide cross-sectional study.
Raygor KP; Phelps RRL; Rutledge C; Raper DMS; Molinaro A; Fox CK; Gupta N; Abla AA
J Neurosurg Pediatr; 2022 Jun; 29(6):602-611. PubMed ID: 35334457
[TBL] [Abstract][Full Text] [Related]
11. Racial/ethnic disparities among Asian Americans in inpatient acute myocardial infarction mortality in the United States.
Kim EJ; Kressin NR; Paasche-Orlow MK; Lopez L; Rosen JE; Lin M; Hanchate AD
BMC Health Serv Res; 2018 May; 18(1):370. PubMed ID: 29769083
[TBL] [Abstract][Full Text] [Related]
12. Clinical features and long-term outcomes of moyamoya disease: a single-center experience with 528 cases in China.
Liu XJ; Zhang D; Wang S; Zhao YL; Teo M; Wang R; Cao Y; Ye X; Kang S; Zhao JZ
J Neurosurg; 2015 Feb; 122(2):392-9. PubMed ID: 25423267
[TBL] [Abstract][Full Text] [Related]
13. The natural clinical course of hemodynamically stable adult moyamoya disease.
Cho WS; Chung YS; Kim JE; Jeon JP; Son YJ; Bang JS; Kang HS; Sohn CH; Oh CW
J Neurosurg; 2015 Jan; 122(1):82-9. PubMed ID: 25361479
[TBL] [Abstract][Full Text] [Related]
14. Clinical course of asymptomatic adult moyamoya disease.
Jo KI; Yeon JY; Hong SC; Kim JS
Cerebrovasc Dis; 2014; 37(2):94-101. PubMed ID: 24435045
[TBL] [Abstract][Full Text] [Related]
15. Increased prevalence of autoimmune disease in patients with unilateral compared with bilateral moyamoya disease.
Chen JB; Liu Y; Zhou LX; Sun H; He M; You C
J Neurosurg; 2016 May; 124(5):1215-20. PubMed ID: 26406790
[TBL] [Abstract][Full Text] [Related]
16. Ten-Year Trend in Age, Sex, and Racial Disparity in tPA (Alteplase) and Thrombectomy Use Following Stroke in the United States.
Otite FO; Saini V; Sur NB; Patel S; Sharma R; Akano EO; Anikpezie N; Albright K; Schmidt E; Hoffman H; Gould G; Khandelwal P; Latorre JG; Malik AM; Sacco RL; Chaturvedi S
Stroke; 2021 Aug; 52(8):2562-2570. PubMed ID: 34078107
[TBL] [Abstract][Full Text] [Related]
17. Plateauing atrial fibrillation burden in acute ischemic stroke admissions in the United States from 2010 to 2020.
Otite FO; Patel SD; Aneni E; Lamikanra O; Wee C; Albright KC; Burke D; Latorre JG; Morris NA; Anikpezie N; Singla A; Sonig A; Kamel H; Khandelwal P; Chaturvedi S
Int J Stroke; 2024 Jun; 19(5):547-558. PubMed ID: 38086764
[TBL] [Abstract][Full Text] [Related]
18. A survey of moyamoya disease in Hawaii.
Graham JF; Matoba A
Clin Neurol Neurosurg; 1997 Oct; 99 Suppl 2():S31-5. PubMed ID: 9409401
[TBL] [Abstract][Full Text] [Related]
19. Incidence and prevalence of moyamoya disease in urban China: a nationwide retrospective cohort study.
Sun Y; Zhou G; Feng J; Chen L; Liu G; Wang J; Wang Q; Yu J; Yang X; Yang Z; Gao P; Wang S; Zhan S
Stroke Vasc Neurol; 2021 Dec; 6(4):615-623. PubMed ID: 33941642
[TBL] [Abstract][Full Text] [Related]
20. Clinical features of moyamoya disease with Graves' disease: a retrospective study of 394,422 patients with thyroid disease.
Hiruma M; Watanabe N; Mitsumatsu T; Suzuki N; Fukushita M; Matsumoto M; Yoshihara A; Yoshimura Noh J; Sugino K; Ito K
Endocr J; 2023 Feb; 70(2):141-148. PubMed ID: 36198616
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
